FDA Approves Iberdomide, the First CELMoD for Relapsed/Refractory Multiple Myeloma
FDA Approves Iberdomide, the First CELMoD for Relapsed/Refractory Multiple Myeloma Targeted Oncology
FDA Issues Emergency Use Authorization for Drug to Treat New World Screwworm in Dogs and Puppies
The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Simparica TRIO (sarolaner, moxidectin, and pyrantel…